Confidentiality agreements are allowing pharmaceutical companies to make billions from secretive deals on life-saving medicines, an investigation by Investigate Europe and its partners has found.
Governments across Europe are unaware of what their counterparts in other countries have paid for a drug – meaning they might pay way over the odds for it or, in many cases, decide they can’t afford it at all.
Twenty-seven-year-old Monika Luty from Poland is among the hundreds of thousands of patients to have suffered as a result of these confidentiality agreements.
